Table 1.
Patients and clinico-histopathological characteristics.
| Characteristic | All (n = 76) |
|---|---|
| Age (years) | 51.32 ± 14.28 |
| T stages | |
| T1 | 6 (8.10%) |
| T2 | 14 (18.91%) |
| T3 | 18 (24.32%) |
| T4 | 36 (48.64%) |
| Missing cases | 2 |
| Nodule status | |
| N0 | 13 (17.6%) |
| N1 | 10 (13.5%) |
| N2 | 30 (40.5%) |
| N3 | 15 (20.3%) |
| Nx | 6 (7.4%) |
| Missing cases | 2 |
| Grade | |
| Grade 1 | 12 (16.4%) |
| Grade 2 | 36 (49.3%) |
| Grade 3 | 25 (34.2%) |
| Missing cases | 3 |
| Stage | |
| Stage I | 3 (4.1%) |
| Stage II | 7 (9.5%) |
| Stage III | 36 (48.6%) |
| Stage IV | 28 (37.8%) |
| Missing cases | 2 |
| Histologic subtype | |
| IDC | 66(86.8%) |
| ILC | 5 (6.6%) |
| MC | 1 (1.3%) |
| MucC | 1 (1.3%) |
| Others | 3 (3.9%) |
| Biomarkers expression | |
| Ki-67 (High) | 65 (85.5%) |
| (Low) | 11 (14.5%) |
| p53 (High) | 30 (39.5%) |
| (Low) | 46 (60.5%) |
| BCL-2 (High) | 44 (57.9%) |
| (Low) | 11 (42.1%) |